series-b
Stage
1
Investors
About
Synergia Medical develops an investigational optoelectronic implantable neuromodulation device for vagus nerve stimulation designed to be MRI-compatible and immune to electromagnetic interference, currently undergoing a first-in-human clinical study in Belgium.
Explore Synergia Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.